News & Updates

Simultaneous COVID-19 and influenza testing can protect high-risk groups

COVID-19 and influenza continue to pose severe public health challenge post-pandemic.

Rapid diagnostic tests that can differentiate between COVID-19 and influenza are essential for accurate diagnosis, care, and treatment.^1,2

Over 39M people could die from superbugs by 2050

More than 39 million people worldwide could die from antibiotic-resistant infections from 2025 to 2050 as the superbug crisis intensifies, according to a new global analysis of antimicrobial resistance.

Original New Drug Application Approvals by US FDA (16-31 October 2024)

New drug applications approved by US FDA as of 16-31 October 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Tailored peritoneal dialysis training program cuts infection, dropout rates

A Singapore hospital has pioneered a tailored peritoneal dialysis (PD) training program that has yielded a significant reduction in PD-related infections and dropouts among patients with end-stage kidney disease (ESKD).

Complications more common in children with long-bone subperiosteal abscess

Children with subperiosteal abscesses (SAs) in the long bones are more likely to have subsequent complications than those with SAs in flat bones, suggests a study.

Which factors predict persistent SAB in children?

A shorter time to culture positivity, osteoarticular infection, and higher presenting and peak values for some inflammatory markers appear predictive of persistent S. aureus bacteremia (SAB) in children, suggests a study.

Colistin effective against nosocomial infections in children

Intravenous colistin therapy demonstrates acceptable efficacy in the treatment of nosocomial Gram-negative bacteria (GNB) infections in paediatric patients, reports a Thailand study.